BMC Medical Co

BMC Medical Co EBITDA per Employee

The EBITDA per Employee of BMC Medical Co (301367.SZ) as of Oct 25, 2026 is 286,658.04 CNY. In the previous year, EBITDA per Employee was 160,371.04 CNY — a change of 78.75% (higher).

EBITDA per Employee

286,658.04CNY

YoY

78.75%

Last updated:

EBITDA per Employee of BMC Medical Co is 2025 286,658.04 CNY. EBITDA per Employee of BMC Medical Co was 2024 160,371.04 CNY. It decreases by 78.75% higher compared to the previous year.

The BMC Medical Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
52,848.75 CNY
Jan 1, 2020
668,311.98 CNY
Jan 1, 2021
192,332.10 CNY
Jan 1, 2022
493,150.87 CNY
Jan 1, 2023
356,726.54 CNY
Jan 1, 2024
160,371.04 CNY
Jan 1, 2025
286,658.04 CNY
The BMC Medical Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
286,658.04CNY+78.75%
160,371.04CNY-55.04%
356,726.54CNY-27.66%
493,150.87CNY+156.41%
192,332.10CNY-71.22%
668,311.98CNY+1,164.57%
52,848.75CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BMC Medical Co Stock analysis

What does BMC Medical Co do? BMC Medical Co. Ltd. generates revenue through the research, development, production, and sale of medical equipment and consumable products focused on respiratory health. The company offers non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices. Its primary customers are patients with sleep apnea-hypopnea syndrome (SAHS), particularly obstructive sleep apnea syndrome (OSA), and patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD). The firm provides chronic disease management services as part of its full-cycle treatment solutions. The company's product portfolio includes non-invasive home ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices, all designed for respiratory health applications. These products target patients suffering from OSA and COPD, addressing both acute and chronic respiratory conditions. BMC Medical Co. Ltd. focuses on delivering comprehensive treatment services through a multi-scenario approach for these specific patient segments. Revenue streams are derived from the sale of medical equipment and consumables, as well as chronic disease management services. The company's services are tailored for patients with SAHS and COPD, providing integrated solutions across the treatment cycle. This includes both the physical products and the ongoing management support for long-term respiratory health needs. BMC Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BMC Medical Co stock

EBITDA per Employee of BMC Medical Co is 286,658.04 CNY in 2025.

EBITDA per Employee of BMC Medical Co changed from 160,371.04 CNY to 286,658.04 CNY, representing a 78.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee BMC Medical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's BMC Medical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — BMC Medical Co

All Key Metrics — BMC Medical Co